Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression (Pergoveris)
Prospective Randomized Study Comparing Ovarian Stimulation With Pergoveris Supported by a GnRH Agonist in a Long Protocol Versus Multidose GnRH Antagonist Regimen in Young Infertile Women Treated With ICS
Sponsor: Merck Serono International SA
This NA trial investigates Complications Associated With Artificial Fertilization and Female Infertility Due to Nonimplantation of Ovum and is currently completed. Merck Serono International SA leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jun 2017 — Jun 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
▶ Show 1 earlier version
-
Jan 2017 — Jun 2017 [monthly]
Unknown Status NA
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Merck Serono International SA
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .